Department of Experimental Clinical Oncology

Error in site JavaScript
Untitled Document

PUBLICATIONS 2001

 

612.      Alsner, J., Høyer, M., Sørensen, S.B. & Overgaard, J.: Interaction between potential doubling time and TPP53 mutation: pridicting outcome of radiotherapy in squamous cell carcinoma of the head and neck. Int. J. Radiat. Oncol. Biol. Phys. 49: 519-525, 2001.

613.      Alsner, J., Sørensen, S.B. & Overgaard, J.: TP53 mutation is related to poor prognosis after radiotherapy, but not surgery in squamous cell carcinoma of the head and neck. Radiotherapy and Oncology 59:179-185, 2001.

614.      Bach, L.A., Bentzen, S.M., Alsner, J. & Christiansen, F.B.: A evulotionary game model of tumour-cell interactions: possible relevance to gene therapy. Eur. J. Cancer 37: 2116-2120, 2001.

615.      Dahl, O. & Overgaard, J.In: Souharmi,R.L., Tannock, I., Hohenberger, H. & Horiot, J-C. (ed)s: Oxford Textbook of Oncology, Second edition, Oxford University Press, Oxford, pp- 511-525, 2001.

616.      Ehrnrooth, E., Grau, C., Zachariae, R. & Andersen, J.: Randomized trial of opiods versus tricyclic antidepressants for radiation induced mucositis pain in head and neck cancer. Acta Oncologica 40: 745-750, 2001.

617.      Grau, C., Jakobsen, M.H., Harbo, G., Svane-Knudsen, V., Wedervang, K., Larsen, S.K. & Rytter, C.: Sino-nasal cancer in Denmark 1982-1991, A nationwide survey. Acta Oncol. 40: 19-23, 2001.

618.      Grau, C., Vendelbo Johansen, L., Jakobsen, J., Geertsen, P., Andersen, E., Bjerregaard Jensen, B.:. Lymfeknudemetastaser på halsen fra ukendt primær tumor. En landsdækkende 20-års opgørelse fra Dansk Selskab for Hoved- og Hals Onkologi. Ugeskr. Læg. 163: 1432-1436, 2001.

619.      Horsman, MR: Book Review. Tumour Hypoxia: Pathophysiology, Clinical Significance and Therapeutic Perspectives. Vaupel, P., Kelleher, D.K. (eds). Int. J. Radiat. Biol 77: 255. 2001.

620.      Horsman, M.R., Murata, R., & Overgaard, J.: Improving local tumor control by combining vascular targeting drugs, mild hyperthermia and radiation. Acta Oncologica 40: 497-503, 2001.

621.      Johansen, L.V., Grau, C. & Overgaard, J.: Squamous cell carcinoma of the nasopharynx. An anaylsis of treatment results in 149 consequtive patients. Acta Oncologica 40: 801-809, 2001.

622.      Ladekarl, M., Grau, C. & Andersen, J.: Nye behandlingsprincipper ved dukalt carcinoma in situ mammae. Ugeskr. Læg. 163: 5014-5017, 2001.

623.      Murata, R.: The vasculature of tumors as a potential target for anti-cancer therapy: A preclinical study in animal tumors. Ph.D. Thesis, Faculty of Health Science, University of Aarhus 2001.

624.      Murata, R., Overgaard, J. & Horsman, MR.: Potentiation of the anti-tumour effect of hyperthermia by combining with vascular targeting agent 5,6-dimethylxanthenone-4-acetic acid.  Int. J. Hyperthermia 17: 508-519, 2001.

625.      Murata, R., Overgaard, J. & Horsman, M.R.: Comparative effects of combretastatin A-4 disodium phosphate and 5,6-dimethylxanthenone-4-acetic acid on blood perfusion in a murine tumour and normal tissues. Int. J. Radiat. Biol. 77: 195-204, 2001.

626.      Murata, R., Overgaard, J. & Horsman, M.R.: Combretastatin A-4 disodium phosphate: a vascular targeting agent that improves that improves the anti-tumor effects of hyperthermia, radiation, and mild thermoradiotherapy.  Int. J. Radiat. Oncol. Biol. Phys. 51: 1018-1024, 2001.

627.      Murata, R., Siemann, D.W., Overgaard, J. & Horsman, M.R.: Interaction between combretastatin A-4 disodium phosphate and radiation in murine tumours. Radiother. Oncol. 60: 155-161, 2001.

628.      Murata, R., Siemann, D.W., Overgaard, J. and Horsman, M.R.: Improved tumor response by combining radiation and the vascular damaging drug 5,6-dimethylxanthenone-4-acetic acid. Radiat. Res. 156: 503-509, 2001.

629.      Nielsen, F.U., Daugaard, P., Bentsen, L., Stødkilde-Jørgensen, H., Overgaard, J., Horsman, M. & Maxwell, R.J.: Effect of changing tumor oxygenation on glycolytic metabolism in a murine C3H mammary carcinoma assessed by in vivo nuclear magnetic ressonance spectroscopy. Cancer Res. 61: 5318-5325, 2001.

630.      Nielsen, O.S., Horsman, M.R. & Overgaard, J.: A future for hypethermia in cancer treatment  (editorial). Eur. J.Cancer 37: 1587-1589, 2001.

631.      Nordsmark, M., Alsner, J., Keller, J., Nielsen, O.S., Jensen, O.M., Horsman, M.R. & Overgaard, J.: Hypoxia in human soft tissue sarcomas: Adverse impact on survival and no association with TP53 mutations. Br.J. Cancer 84: 1070-1075, 2001.

632.      Nordsmark, Longcaster, J., Chou, S-C., Havsteen, H.Lindegaard, J., Davidson, S., Varia, M., West, C., Hunter, R., Overgaard, J. & Raleigh, J.A.: Invasive oxygen measurements and pimonidazole labeling in human cervix carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 49: 581-586, 2001.

633.      Offersen, B.V., Pfeiffer, P., Hamilton-Dutoit, S.,& Overgaard, J.: Patterns of angiogenesis in non-small-cell lung carcinoma. Cancer 91: 1500-1509, 2001.